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ScienceDirectThe associations between higher intelligence test scores from
early life and later good health, fewer illnesses, and longer life are
recent discoveries. Researchers are mapping the extent of these
associations and trying to understanding them. Part of the
intelligence-health association has genetic origins. Recent
advances in molecular genetic technology and statistical analyses
have revealed that: intelligence and many health outcomes are
highly polygenic; and that modest but widespread genetic
correlations exist between intelligence and health, illness and
mortality. Causal accounts of intelligence-health associations are
still poorly understood. The contribution of education and socio-
economic status — both of which are partly genetic in origin — to
the intelligence-health associations are being explored.
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Intelligence, and health and death
Until recently, an article on DNA-variant commonalities
between intelligence and health would have been science
fiction. Thirty years ago, we did not know that intelligence
test scores were a predictor of mortality. Fifteen years ago,
there were no genome-wide association studies. It was less
than five years ago that the first molecular genetic correla-
tions were performed between intelligence and health
outcomes. These former blanks have been filled in; how-
ever, the fast progress and accumulation of findings in the
field of genetic cognitive epidemiology have raised more
questions. Individual differences in intelligence, as testedCurrent Opinion in Psychology 2019, 27:6–12 by psychometric tests, are quite stable from later childhood
through adulthood to older age [1,2]. The diverse cognitive
test scores that are used to test mental capabilities form a
multi-level hierarchy [1–3]; about 40% or more of the
overall variance is captured by a general cognitive factor
with which all tests are correlated, and smaller amounts of
variance are found in more specific cognitive domains
(reasoning, memory, speed, verbal, and so forth). Twin,
family and adoption studies indicated that there was mod-
erate to high heritability of general cognitive ability in
adulthood (from about 50–70%), with a lower heritability
in childhood [4]. It has long been known that intelligence is
a predictor of educational attainments and occupational
position and success [1].
Relatively recently, the ‘ultimate validity’ of intelligence
test scores was discovered, that is, that higher intelligence
significantly predicts later death. First, an Australian Viet-
nam Veterans study found that higher young-adult intelli-
gence predicted lower risk of accidental deaths up to early
middle age [5]. Then, a population-representative Scottish
study found that intelligence test scores at age 11 years
predicted deaths from all causes up to older age (the mid-
70 s) [6]. The association between intelligence test scores
from early life and mortality from all causes has been widely
replicated [7–9]. Intelligence from childhood and adult-
hood is associated with most of the major causes of death
with the exception of non-smoking-related cancers
[10,11]. Broadly speaking, a one-standard-deviation
advantage in intelligence in youth lowers the risk of mor-
tality by 20–25% or more up to older age; the effect sizes are
hardly attenuated at all by adjusting for childhood socio-
economic status, though are partly attenuated after adjust-
ing for education and adult socio-economic status, which
are possible mediators of the association [6,7,8,9,10,11].
In addition to mortality, intelligence test scores are asso-
ciated with lower risk of many morbidities, such as
cardiovascular disease, cerebrovascular disease, hyperten-
sion, cancers such as lung cancer, stroke, and many others,
as obtained by self-report and objective assessment [12–
14]. Higher intelligence in youth is associated at age
24 with fewer hospital admissions, lower general medical
practitioner costs, lower hospital costs, and less use of
medical services, and intelligence appeared to account for
the associations between education and such health out-
comes [15,16]. Higher intelligence is related to a higher
likelihood of engaging in healthier behaviours, such as not
smoking, quitting smoking, not binge drinking, having awww.sciencedirect.com
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taking more exercise, and eating a healthier diet [16–18].
The flood of intelligence versus mortality/illness/health-
behaviours findings was captured by the term ‘cognitive
epidemiology’ [19]. From early on until now, there have
been speculations about the possible causes of these
associations [6,10,14,20]. Briefly, there is acknowledge-
ment that the causes of the associations are probably
multiple, such as there being a constitutional (perhaps
partly genetic) association between intelligence and
health, and/or that intelligence’s influence might act
via more education, higher health literacy, and more
affluent social class. Here, we examine evidence for
possible genetic links between intelligence and health.
Genetic contributions to health, and to
intelligence
There are at least three reasons to conduct genetic studies
of phenotypes. First one wants to understand the genetic
architecture of a phenotype, that is, what is the nature of
the genetic variants that contribute to variation in the
phenotype. For example, a single mutation might have a
large effect, as is the case in Mendelian diseases. By
contrast, continuous traits might be more likely to be
polygenic; that is, to have some of their variance caused
by small contributions from many genetic variants. Sec-
ond, having discovered the genetic architecture, one is
interested in the specific genes in which variants have
causal effects, that is, one wants to understand the molec-
ular genetic mechanisms of variation. Third, knowing that
there is some genetic contribution to a phenotype, one
can ask how good a predictor the genotypic information is;
that is, how well can one predict some variation in a
phenotype from only genotypic information? Much
recent progress has been made along these lines for
illnesses and for intelligence.
Before the mid-2000s, genetic studies were done by three
main methods. First, pedigree-based (twins, adoptees,
and families) studies of relatives’ phenotypic associations
were used to estimate the heritability of phenotypes, and
genetic correlations among them. Limitations of pedigree
methods include the fact that several assumptions must
be made in doing the modelling, and that one does not
learn about the specific genes involved. Second, candi-
date gene studies tested hypotheses concerning whether
certain genetic variants were associated with phenotypic
differences. For example, the possession of the e4 allele
of the gene for Apolipoprotein E (APOE) is associated
with an increased risk of developing Alzheimer’s disease.
Limitations of the candidate gene method include the
fact that most candidate gene findings are not replicated
(APOE e4 possession is an exception to this), and that it is
difficult to choose a candidate genetic variant from the
millions that are known. Third, genetic linkage analysis
was used to track genetic markers in families wherewww.sciencedirect.com specific phenotypes were common, to identify regions
of the genome that segregate with the phenotype. The
main limitations of this method are that large families are
required and it identifies relatively large regions of the
genome, rather than specific genetic variants or genes.
This changed with the advent and rise of genome-wide
association studies (GWASs) [21] (See Box 1). Sample
sizes for GWASs often began with a few thousand, but, as
the polygenic architecture of many traits became clear — ,
that is, the associations between individual genetic var-
iants and phenotypes typically had very small effect
sizes — it was necessary to form consortia so that the
Ns of studies rose to the tens and then hundreds of
thousands. Some GWAS consortia are now approaching
and passing one million participants.
The typical finding — there are exceptions — in health
and cognitive GWASs is that many genetic variants of
small effect contribute to phenotypic variation. In 2017, a
survey of the first ten years of GWASs’ discoveries enu-
merated the SNPs that were associated with, for example,
Crohn’s disease, diabetes, blood lipid levels, heart func-
tion, height, bone density, red blood cell traits, metabolic
traits, blood platelets, breast cancer, rheumatoid arthritis,
blood metabolites, menarche, Alzheimer disease, kidney
function, lung function, and education [21]. Often, the
numbers of genetic loci in which significant SNP associa-
tions are found runs to dozens or even hundreds for a
single phenotype.
In 2011 the first apparently-decently-sized GWAS of
intelligence appeared (N approximately 3500), and found
no significant SNPs [22]. By the time the sample size was
about 100 times greater, the number of independent
genomic regions that were associated with intelligence
was about or greater than 150 [23,24,25]. Figure 1
shows results from a recent GWAS of intelligence. Many
of these SNPs are located in regions of the genome that
have previously been associated with physical and mental
illnesses. Therefore, we now know many actual DNA
variants that have significant associations with intelli-
gence tests’ scores; there are probably thousands in total.
Although it found no significant SNPs, the 2011 paper
[22] did make a difference; it was the first study to
estimate the heritability of intelligence from DNA data
alone and in unrelated subjects. This used a then-new
method—called GREML, and run in the GCTA frame-
work [26] — which examined people’s overall genetic
similarity — based on common SNPs — with their phe-
notypic similarity (See Box 1). The common-SNP-based
heritability of intelligence is estimated to be about 25%
[24]. It is typical for this common-SNP-based heritability
to be about half of that estimated from twin studies [27].
It is thought that this ‘missing heritability’ is because
there are types of genetic variants other than causal
variants that are in linkage disequilibrium with commonCurrent Opinion in Psychology 2019, 27:6–12
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Box 1 Methods for investigating shared genetic aetiology between intelligence and physical health, illness and mortality
1. Genome-wide association study (GWAS)
GWAS is used to identify genetic variants associated with phenotypes. For diseases, large numbers of cases and controls are genotyped using
testing arrays, most commonly from the companies Illumina or Affymetrix. The arrays contain up to 1 million genetic variants spread throughout the
genome. For quantitative traits, large numbers of individuals on whom the trait is measured are genotyped. Using reference datasets, for example,
Hap Map, 1000 Genomes and the haplotype reference consortium (HRC), several million genetic variants are then imputed to give greater genomic
coverage and to harmonize datasets genotyped using different genetic testing arrays, containing different variants. Logistic (for case control) or
linear (for quantitative traits) regressions are then performed between each genetic variant and the phenotype. As millions of regressions are
performed for each phenotype a P-value of <5  108 is usually considered genome-wide significant. As GWASs do not analyse every variant in the
genome they do not usually identify causative variants, but rather indicate regions of the genome that are implicated in a particular phenotype. If the
same regions of the genome are identified in GWASs of multiple phenotypes this may indicate that the phenotypes share genetic aetiology.
2. Genome-wide complex trait analysis (GCTA)-genomic-relatedness-based restricted maximum-likelihood single component (GREML)
GREML [26] is used to estimate the proportion of variance in a phenotype that is due to the linkage disequilibrium between genotyped variants and
unknown causal variants. It gives a lower-boundary estimate of the heritability of a phenotype as it does not include variance accounted for by
genetic variants that are not well tagged by variants on the array, for example, rare variants.
3. Bivariate GCTA
Bivariate GCTA [46] is an extension of GCTA-GREML that allows the genetic correlation between two phenotypes to be determined. Genetic
correlation describes the proportion of the variance that two phenotypes share that is due to genetic causes. High genetic correlation between two
phenotypes indicates that the phenotypes share genetic aetiology. This method requires the actual genotyping data from the sample and for the
sample to have been measured on the two phenotypes in question.
4. Linkage disequilibrium (LD) regression
LD regression [30,31] is a method that can be used to determine the genetic correlation between two phenotypes, using only summary statistics
from GWASs. LD regression estimates the genetic effect on a trait by measuring the extent to which the observed effect sizes from a GWAS can be
explained by LD. The covariance between the genetic effects in two phenotypes can be indexed in a similar way; normalizing this genetic
covariance by the heritability of the trait will estimate the genetic correlation between the two traits. This method does not require genotyping data,
and can produce genetic correlations for two phenotypes that were GWAS-ed on different samples. For example LD regression is used to compute
the genetic correlation between intelligence and longevity by using summary statistics from a GWAS of mortality and a GWAS of intelligence, both
conducted on independent samples.
5. Polygenic scores (PGS)
PGS analysis uses summary GWAS data for a given phenotype to test whether polygenic liability to that phenotype is associated with the same or
different phenotype measured in an independent sample. It allows the amount of variance in one phenotype attributed to the polygenic score for
the same or a second phenotype to be calculated. A PGS for a particular phenotype can be calculated for each individual in a sample, by summing
the known effect size of each individual SNP (obtained from a GWAS of that phenotype) multiplied by the number of reference alleles present for
that SNP in a particular individual. PGSs can be calculated using PRSice [47]. For example, the polygenic score for risk of coronary artery disease is
associated with cognitive ability in older adults [48].
6. Mendelian Randomization (MR)
The methods described above will indicate whether or not two phenotypes share genetic aetiology, but do not reveal the direction of causation.
Once shared genetic aetiology between two phenotypes is established, MR methods can be used to investigate whether one phenotype directly
influences the other phenotype, or whether genetic variants independently affect both phenotypes. Bi-directional MR allows each phenotype to be
used as the exposure or the outcome in turn, potentially providing support for the direction of effect. In MR, genetic variants (often variants that are
genome-wide significantly associated with the relevant phenotype) are used as instrumental variables (IV) for the exposure. Unlike the exposure
itself, these genetic variants should be largely independent of confounding factors and reverse causation. The IV is used to estimate if the exposure
causally influences the outcome. There are three basic assumptions of MR: Firstly, the genetic variants are associated with the exposure; secondly,
the genetic variants are only associated with the outcome of interest via their effect on the exposure; and finally, the genetic variants are
independent of confounders of both the exposure and the outcome. Biological pleiotropy, whereby a genetic variant independently influences
multiple traits, may violate the second assumption. The more SNPs that make up the IV the more likely that biological pleiotropy will be present.
Methods have now been developed that test and correct for biological pleiotropy [49]. Two-sample MR allows the exposure and the outcome to be
measured in different samples and therefore the effect of the IV on the exposure and outcome can be obtained from GWAS summary data [50].SNPs that contribute to heritability. Some new techni-
ques are helping to find these and close the gap between
twin-based and SNP-based heritability [28].
Genetics and the intelligence-health
relationship
Three things are clear. First, higher intelligence in early
life is a significant predictor of better health behaviours,
fewer and later illnesses, and longer life. Second, many of
the relevant health and illness outcomes, as well as healthCurrent Opinion in Psychology 2019, 27:6–12 behaviours, have many SNPs associated with them, and
have a detectable level of common-SNP-based heritabil-
ity. Third: the same goes, genetically, for intelligence.
Relatively new methods — bivariate extension of
GREML run on GCTA [29], and LD regression
[30,31] (see Box 1) — have allowed estimates of the
genetic correlations between phenotypes. That is, we
can test the extent to which the polygenic signature
obtained by using the summary results from GWAS
contributes to any two phenotypes, including betweenwww.sciencedirect.com
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This is a ‘Manhattan plot’, taken from Davies et al.’s genome-wide association study of 300,486 participants on general cognitive function [24].
Chromosome number is shown on the X-axis, with each dot representing one of the more than 12 million imputed single nucleotide
polymorphisms. The red line represents genome-wide significance, that is, P < 5  108.intelligence and health. Polygenic signatures for many
diseases were soon shown to be associated with intelli-
gence [32]. Twin studies had suggested that part of the
intelligence-mortality association might be genetic in
origin, though there was disagreement about how much
genetics contributed [33,34]. However, more recent stud-
ies have used genomic data.
The list of significant molecular genetic correlations
between intelligence and physical health variables is
now long [23,24,25,32]. Table 1 gives some examples.
With regard to mortality, longevity has been used; paren-
tal age at death has also been used, as a proxy, because
most relevant studies have not carried on long enough for
many participants to have died. There is a positive
correlation of 0.36 between intelligence and parental
age at death. There are inverse genetic correlations
between intelligence and both heart disease and hyper-
tension, with effect sizes between 0.1 and 0.2. There
is a small (<0.1) association with cholesterol, with higher
‘good’ cholesterol going with higher intelligence and the
reverse for the ‘bad’ cholesterol. There is a moderate-
sized inverse genetic association between intelligence
and Alzheimer’s disease. There is a positive genetic
association, of 0.27, with intracranial volume, which is
an indication of maximal brain volume in the life course.
There are significant positive genetic correlations
between intelligence and birth weight, lung function,www.sciencedirect.com happiness, and short-sightedness. There are significant
negative genetic correlations between intelligence and
body mass index, poor self-rated health, lung cancer,
osteoarthritis, insomnia, smoking, waist-hip ratio, and
long-sightedness. It must be stressed that these correla-
tions are based on GWASs conducted on different sam-
ples; that is the people on whom intelligence was mea-
sured were not the people on whom the health-based
phenotype was assessed. Associations are interesting, but
they do not explain why the correlations exist, or the
direction of causation, which require further study and
more new GWAS-based methods.
Understanding the intelligence versus
physical health association, including the part
played by genetics
As described above, genetic correlations have been iden-
tified between intelligence and many diseases, and phys-
ical health traits; moreover, polygenic scores for diseases
and health traits predict intelligence. However, it is not
clear if these findings are due to: (1) genetic variants
influencing health traits/diseases, and then those health
traits/diseases influencing intelligence; (2) genetic var-
iants influencing intelligence, and then intelligence influ-
encing health traits/diseases; or (3) genetic variants influ-
encing general bodily system integrity [20] that
influences both intelligence and health traits/diseases.
(1) and (2) may be due to mediated pleiotropy whichCurrent Opinion in Psychology 2019, 27:6–12
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Table 1
Genetic correlations (rg, with P values) between intelligence and health outcomes from Hill 2018 [23], Davies 2018 [24], and Savage
[25].
Phenotype category Phenotype Hill, 2018 [23] Davies, 2018 [24] Savage, 2018 [25]
rg P rg P rg P
Vascular-metabolic Angina 0.18 7.58  109
Coronary artery disease 0.17 1.03  106 0.11 0.0024 0.19 1.23  107
HDL cholesterol 0.092 8.10  106
Heart attack 0.17 4.74  107
Hypertension 0.15 2.44  1014
LDL cholesterol 0.055 0.019
Triglycerides 0.052 0.027
Type 2 diabetes 0.09 0.0077 0.073 0.043 0.042 0.33
Brain measures Infant head circumference 0.28 7.18  105
Intracranial volume 0.27 1.56  105 0.25 6.56  109
Physical and physiological Age at Menopause 0.13 1.10  105
Alzheimer’s disease 0.38 0.00010 0.37 2.78  105 0.26 3.95  105
Birth length 0.16 3.88  103
Birth weight 0.11 2.09  106 0.10 0.12
BMI 0.16 1.38  1016 0.13 8.38  1012 0.12 1.64  106
Chronotype 0.15 1.45  108
Fathers age at death 0.37 4.75  1033
FEV1 0.10 0.00037 0.19 1.33  1019
Hand grip strength (right) 0.086 4.08  105
Happiness 0.086 9.2  103
Head circumference 0.31 1.33  108
Health satisfaction 0.26 3.43  1021
Height 0.12 1.13  1014 0.082 4.96  104
Longevity 0.17 0.0036 0.43 4.91  108
Lung cancer 0.26 4.73  109
Mothers age at death 0.48 5.82  1030
Obesity 0.18 9.3  1014
Osteoarthritis 0.24 3.78  1011
Overall poor health rating 0.39 7.69  10105
Parents age at death 0.37 0.0094 0.36 3.5  1010
Self-rated health 0.46 1.37  1083
Sleeplessness/insomnia 0.12 7.27  108
Smoking status 0.27 2.9  1014 0.20 5.61  108 0.15 2.61  103
Tiredness 0.18 8.28  109
Waist circumference 0.10 9.69  105
Waist-hip ratio 0.17 4.02  1014 0.17 8.6  1010
Wears glasses or contact lenses 0.28 2.12  1013
Longsighted-ness 0.21 2.04  105
Shortsighted-ness 0.32 1.92  1024
Note: Samples contributing to the three papers are not independent. Variables with no significant genetic correlation with intelligence in any of the
three studies were not included. P values shown are nominal; some do not survive Bonferroni correction or correction for false discovery rate, as
indicated in the three papers.can be tested for using a relatively new technique called
Mendelian Randomization (MR) (see Box 1).
Using a bi-directional two-sample MR approach we iden-
tified no causal association between intelligence or edu-
cational attainment (a proxy measure of intelligence), and
the physical health traits of body mass index (BMI),
systolic blood pressure, height, coronary artery disease
and type 2 diabetes [35], using data from the UK Biobank
(N approximately 110,000) and large GWAS consortia.
However, a larger, more-recent study found MR-based
evidence for potentially causal genetic effects of intelli-
gence on larger intracranial volume, lower risk of
Alzheimer’s disease, lower body mass index, and greaterCurrent Opinion in Psychology 2019, 27:6–12 likelihood of quitting smoking [25]. A MR study inves-
tigating the effect of education on obesity in about
2000 Finns concluded that education could be a protec-
tive factor against obesity, as measured using BMI [36].
Another study using education data from the SSGAC
consortium and coronary heart disease data from CAR-
DIoGRAMplusC4D (total sample size = 543,733) found
that higher education was causally associated with
reduced risk of coronary heart disease, lower likelihood
of smoking, lower BMI and a more favourable blood lipid
profile [37]. Sensitivity tests indicated that the results
were unlikely to be driven by biological pleiotropy. A two-
step MR study investigated the influence of vitamin B12
intake during pregnancy on cord blood DNA methylationwww.sciencedirect.com
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cognition in the Avon Longitudinal Study of Parents and
Children (ALSPAC) [38]. A small causal effect of vitamin
B12-responsive DNA methylation changes on children’s
cognition was identified. MR analysis has suggested that
genetically-predicted intelligence and education both
had associations with Alzheimer’s disease [39].
Another part of understanding the genetic contribution to
intelligence-health correlations concerns other predictors
of health inequalities, and intelligence’s correlations with
them. Intelligence, we saw earlier, is related to education
and socio-economic status (SES), and those were known
to be related to health inequalities before intelligence was
known to have health associations. Although education
and SES are principally thought of as social-environmen-
tal variables, both have been found to be partly heritable,
by both twin-based and molecular genetic studies, both
have high genetic correlations with intelligence, Mende-
lian Randomisation results show bidirectional genetic
effects between intelligence and education, and both
have genetic correlations with health outcomes
[25,40,41,42,43,44,45].
Conclusion
Intelligence has predictive power for many health out-
comes. Part of that association is genetic. The genes
involved, and the causal pathways of the associations
are being explored.
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